The NOrdic-Baltic Randomized Registry Study for Long-term Clinical Evaluation of Adjunction of PCI to Optimal Medical Therapy in Chronic Total Coronary Occlusion
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Randomized registry for the study of CTO PCI as adjunction to optimal medical therapy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• ≥1 CTO lesion amenable to PCI.
• Stable and stabilized coronary artery disease
• Symptoms (angina pectoris or shortness of breath) and/or signs of reversible perfusion defect by SPECT, PET or MR and/or angiographic/echocardiographic indication of reversible ischemia.
• CTO lesion in a major coronary vessel supplying a significant myocardial territory (vessel diameter usually ≥3mm).
Locations
Other Locations
Denmark
Aalborg University Hospital
RECRUITING
Aalborg
Contact Information
Primary
Martin K Christensen, MD
m.kirk@rn.dk
+45 9766 4454
Backup
Leif Thuesen, MD
leif.thuesen@rn.dk
+45 9766 4465
Time Frame
Start Date: 2018-06-01
Estimated Completion Date: 2030-07-01
Participants
Target number of participants: 2000
Treatments
Active_comparator: Initial conservative treatment
Optimal medical therapy and option for crossover after 6 months or fulfillment of certain conditions
Experimental: initial interventional treatment
CTO PCI attempt as initial strategy with medical optimization simultaneously
Related Therapeutic Areas
Sponsors
Leads: Leif Thuesen